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Previewsinvestigators prioritize candidate genes
for functional studies.
As a final step, the authors sought
to determine to what degree murine
gliomas might recapitulate gene expres-
sion subclasses of human glioblastoma
described in prior studies (Phillips
et al., 2006; Verhaak et al., 2010). Unsu-
pervised hierarchical clustering analysis
across p53:Pten and p53:Pten:Rb1
tumors generated three clusters of murine
gliomas, HC1, HC2, and HC3, with signif-
icant similarity to proneural and mesen-
chymal subclasses of GBM. One inter-
esting deviation from the human data,
however, was that correlation of the
mouse histology and genetics with the
murine expression subclasses was weak,
yet such correlations are clearly present in
human GBM, particularly for the mesen-
chymal subclass that is associated with
NF1 loss, necrosis, and inflammation.
While further refinement of mouse-to-
human expression correlations is likelyrequired, the results support the idea
that mouse glioma models could be very
helpful in exploring the diversity of human
GBM subclasses with implications for
better diagnosis and prediction of prog-
nosis in patients. What seems equally
clear is that mouse models can still
generate novel ways to surprise and
inform investigators who seek to under-
stand these most challenging cancers of
the brain.REFERENCES
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Reactive oxygen species (ROS) mediate various cell fate decisions in normal and transformed cells. In this
issue of Cancer Cell, Zhu et al. demonstrate the ability of ANGPTL4 to engage integrin-dependent survival
signals by activation of the NADPH oxidase Nox1, thus mimicking anchorage conditions and bypassing
anoikis by controlling ROS.Cancer cells have long been known to
display abnormal redox metabolism,
releasing increased levels of reactive
oxidants compared with normal cells.
The exact significance of such reactive
oxygen species (ROS) production as it
pertains to malignant transformation,
however, has been less clear. ROS cause
oxidative stress, which results in muta-
tions to both nuclear and mitochondrial
DNA. With loss of fail-safe death andsenescence mechanisms, such genomic
damage has been proposed to accelerate
transformation and cancer progression.
Besides creating a stress response,
however, ROS clearly participate in phys-
iologic signaling at a variety of levels,
requiring tight spatial and temporal regu-
lation of oxidants by normal cells (Terada,
2006). In this capacity, ROS control prolif-
eration, differentiation, junction formation,
and response to cytokines and othersoluble factors. Given their propensity to
produce increased levels of ROS, are
cancer cells able to appropriate these
oxidant-dependent signals as a means
of dysregulating proliferative and survival
pathways? In this issue of Cancer Cell,
Zhu et al. (2011) uncover a role for angio-
poietin-like 4 (ANGPTL4) in activating
integrin-related, oxidant-dependent sur-
vival pathways, despite the loss of matrix
attachment. This highjacking of normal9, March 15, 2011 ª2011 Elsevier Inc. 297
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Previewsanchorage-sensing mechanisms sheds
further light on the complex role of ROS
in malignant cell behavior.
ANGPTL4 has previously been shown
to regulate lipid metabolism; interestingly,
fasting and hypoxia induce ANGPTL4,
suggesting its possible importance in the
tumor microenvironment. Accordingly,
upregulation of ANGPTL4 predicts
metastasis of breast cancer to the lung,
possibly by preparing the lung microvas-
cular bed for efficient tumor cell extrava-
sation (Padua et al., 2008). In the present
study, Zhu et al. (2011) first survey
ANGPTL4 expression in normal and
neoplastic cells and tissue and find
elevated protein and mRNA levels in
adenomas and carcinomas from a variety
of tissues besides breast, suggesting
broad relevance in human cancers.
Further, in knockdown or knockout stu-
dies of both human skin carcinoma
xenograft and mouse melanoma tumor
models, the authors show that ANGPTL4
supports tumor growth in an autocrine
or paracrine fashion. Of importance,
treatment with an antibody against
ANGPTL4 significantly retards melanoma
growth in the mouse model, indicating
that this pathway may be clinically
targetable.
The authors further studied the effects
of ANGPTL4 on attachment sensation
by tumor cells. Anchorage independence
is a well-known mesenchymal phenotype
that allows carcinomas to metastasize
and possibly to expand as a mass
without consistent basement membrane
contact. The mechanisms by which
normal epithelioid cells sense attachment
and are committed to death following
detachment are not well understood, but
clearly involve outside-in integrin signals.
Here, the authors demonstrate direct
binding of ANGPTL4 to b1 and b5 integ-
rins, resulting in the activation of both
Rac1 and FAK and the downstream acti-
vation of Src, Akt/PKB, and ERKwith con-
sequent protection from anoikis. Thus,
ANGPTL4 is capable of falsely reporting
anchored conditions through integrin
binding.
The composition of the integrin-related
signaling complex that reports anchorage
conditions is not well understood. Rac1 in
particular is critical to coupling integrin
ligation with cell cycle progression (Met-
touchi et al., 2001). Among a number of
Rac1 effectors, several members of the298 Cancer Cell 19, March 15, 2011 ª2011 ENADPH oxidase (Nox) family are of poten-
tial relevance in this regard. Increased
ROS have been associated with both
detachment from and attachment to
matrix, and are thought to transduce
either death or survival signals. In the
latter instance, oxidative activation of
Src has been shown to mediate survival
effects (Giannoni et al., 2005), though
the specific oxidant source has been
less clear. Of note, the Nox adaptor
p47phox translocates to focal complexes
and initiates local Rac1 and Src-depen-
dent redox signaling in migrating cells,
indicating Nox signaling that is restricted
to sites of nascent integrin clustering
(Wu et al., 2005). This adaptor serves
Nox1 as well as Nox2, which both require
Rac1 for activation.
In the present article, the authors clearly
demonstrate Nox1 as the predominant
oxidase mediating ANGPTL4/b1-2 integ-
rin-dependent survival signals (Zhu et al.,
2011). Identification of this particular
oxidase is notable, as it was originally
described as a mitogenic oxidase associ-
ated with cell transformation (Suh et al.,
1999). Indeed, subsequent studies have
linked Nox1 induction, downstream from
oncogenic Ras, with anchorage indepen-
dence and tumorigenesis (Mitsushita
et al., 2004). More recently, Nox1 has
also been shown to mediate b1 integrin
signaling during directional migration
and wound repair (Jun and Lau, 2010;
Sadok et al., 2009), suggesting a broader
role for Nox1 in mediating b1 integrin
signaling. Together, these data suggest
that Nox1 may exert its signaling effects
primarily through its integration into
specific integrin complexes.
This study has interesting implications
and raises several general questions.
First, the ability of ANGPTL4 to activate
PI3K and ERK pathways suggests a
common involvement of Ras, whose
effects are known to be linked to integrin
ligation context. While the authors did
not specifically examine Ras involvement,
Ras and Nox control broadly overlapping
cellular functions, including proliferation,
survival, cell shape change, and motility.
Ras has been shown to be activated
downstream of oxidants, either through
direct cysteine modification or through
upstream events; conversely, oncogenic
Ras is known to exert mitogenic effects
through ROS. In addition, both Ras and
Noxgene families aroseearly in eukaryoticlsevier Inc.evolution, appear to collaborate in specific
developmental and morphologic adapta-
tions toenvironmental stress, andcolocal-
ize in relevant signaling compartments.
Thus, it is conceivable that ANGPTL4
may feed into an evolutionarily conserved
environment-sensing pathway.
One question raised is the relevance of
the specific oxidant produced. While the
authors correlate ANGPTL4 effects with
changes in O2-:H2O2 ratios, caution
should be exerted with respect to the
significance of this ratio. First, one rarely,
if ever, encounters O2- without H2O2,
owing to its rapid spontaneous dismuta-
tion, making it often difficult to distinguish
the effects of one oxidant species from
the other in vivo. Second, despite their
differing chemical reactivity, common
molecular targets have been ascribed to
both. For instance, Src oxidation during
cell adhesion, as postulated in the present
study, is blocked by PEG-catalase, indi-
cating H2O2 and not O2- as the proximal
ROS (Giannoni et al., 2005). Third, it is
probable that the observed changes in
O2-:H2O2 ratios reflect alterations in
activity of specific oxidases induced by
the various interventions. A shift in the
activity or presence of various oxidases,
which are differentially localized and regu-
lated, is more likely to be responsible for
changes in signal output. For example,
Nox4, a predominantly H2O2-producing
Nox, is localized to the ER and mediates
ER stress signaling and cell fate deci-
sions, and may in part be responsible for
the increase in cell death.
Perhaps the most interesting question
has to do with how ANGPTL4 can fool
the cell to believe that it is anchored to
a solid environment. Soluble matrix frag-
ments or peptide-coated microspheres
will ligate and cluster integrins but not
prevent anoikis, suggesting that proper
anchorage sensing requires a mechanical
readout of the stiffness of the surrounding
matrix, beyond simple integrin ligation.
Such mechanosensation appears to re-
quire RhoA-dependent tension against
the underlying solid matrix (Ma et al.,
2007). In this regard, it is noteworthy that
Nox1 locally inactivates RhoA (Sadok
et al., 2009), offering a possible means
to defeat this tension test. Further study
of this integrin-related signaling complex
will lead to deeper insight into the mecha-
nism of anchorage sensing and its loss in
cancer cells.
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In this issue of Cancer Cell, Finley and coworkers report that the genetic loss of the deacetylase SIRT3 leads
to metabolic reprogramming toward glycolysis. This shift is mediated by an increase in cellular reactive
oxygen species (ROS) generation that amplifies HIF-a stabilization and HIF-dependent gene expression,
thereby driving the tumor phenotype.In cancer cells, reprogramming of cellular
metabolism drives substrate utilization
toward a dependence on glucose.
First described by Otto Warburg (War-
burg, 1956), the significance of this
response for tumor growth has been
controversial. However, it appears that
this glycolytic shift is necessary to
provide a source of substrates for the
synthesis of amino acid, lipids, and
nucleic acids that are needed for prolifer-
ation (Vander Heiden et al., 2009).
Indeed, enhanced glucose uptake by
tumor cells forms the basis for the clinical
detection of tumors by imaging regions
exhibiting increased uptake of the
glucose analog 18F-fluordeoxyglucose.
While the association between cancer
and the Warburg metabolic shift is well
established, the cellular mechanisms
regulating this response are not fully
understood.
Posttranslational modifications of pro-
teins are important for regulating their
function in health and disease. Critical
roles for protein deacetylases are alsoemerging in cancer. For example, Kim
et al. (2010) identified a role for SIRT3,
a member of the seven-member sirtuin
family, as a tumor suppressor. They
showed that genetic deletion of SIRT3
pushes the cell in the direction of onco-
genic transformation. While activation of
two oncogenes (such as Myc and Ras)
is needed to transform an immortalized
fibroblast into a tumor-forming cell,
genetic deletion of SIRT3 reduced that
number to one. Thus, SIRT3 functions
as a tumor suppressor (Schumacker,
2010). The mechanistic basis for SIRT3’s
tumor-suppressive role seems to reside
in its ability to regulate reactive oxygen
species (ROS) generation or clearance
by the cell. Kim et al. (2010) noted that
ROS levels were increased in SIRT3/
cells, as a consequence of a decreased
expression of antioxidant enzymes such
as catalase and MnSOD. The transcrip-
tion factor FOXO3a plays an important
role in regulating the expression
of MnSOD and other antioxidants,
and SIRT3-mediated deacetylation ofFOXO3a promotes its nuclear localization
(Jacobs et al., 2008). Thus, the loss of
SIRT3 activity suppresses FOXO3a,
leading to an increase in cellular ROS
signaling. Enhanced ROS levels have
been linked to cancer, and Kim et al.
(2010) observed an increase in the inci-
dence of mammary tumors in the SIRT3
knockout mice. They suggested that
the chronic increase in mitochondrial
ROS stress might result in mitochondrial
or genomic DNA damage, but that
mechanism was not directly tested.
Nevertheless, their study identified an
important pathway by which SIRT3
suppresses tumor cell survival and prolif-
eration through its effects on cellular ROS
regulation.
But even the best studies leave many
questions unanswered. The principal
issue left in the wake of the Kim et al.
(2010) study related to how the increase
inROS (causedby lossof SIRT3)mediates
the enhanced tumor phenotype of
cells. The answer to that question arrives
in the article by Finley et al. (2011) in this9, March 15, 2011 ª2011 Elsevier Inc. 299
